by Mann S
Mann S. Self-care with systemic antibiotics in New Zealand – will data have an impact elsewhere? SelfCare 2012;3(6):113-114
by Mann S
by Gauld N
Gauld N. Improving access to urinary tract infection treatment: The reclassification of trimethoprim. SelfCare 2012;3(6):115-120
The recent reclassification of trimethoprim in New Zealand (NZ) will allow women with symptoms of a lower urinary tract infection (UTI) more timely access to an effective treatment. This decision contrasts with the withdrawal of similar nitrofurantoin and trimethoprim applications in the United Kingdom (UK) in 2010.
by Soller RW, Shaheen C
Soller RW, Shaheen C. The Switch Considerations List: ‘Considerations for Rx-to-OTC Switch’ Refined by a Critical Synthesis of FDA Comments on Expanded Access for Naloxone. SelfCare 2012;3(6):121-137
The Food and Drug Administration (FDA) recently held a meeting to explore new paradigms for drug availability under the regulatory rubric of novel conditions of nonprescription drug use. Subsequent to this meeting, FDA held a workshop on naloxone for prevention of death from opioid overdose. This represented the first publicly discussed switch candidate for novel conditions of nonprescription drug use.
by Mulvaney M, Soller RW, Rice L, Negerete MJ
Mulvaney M, Soller RW, Rice L, Negerete MJ. Warnings in OTC print advertisements – Poster. SelfCare 2012;3(6):138. Poster1
The aim of this section is to encourage the publication of student/junior faculty research projects, offering an opportunity for young and more seasoned junior researchers to publish their research in this form. Poster submissions are subject to an independent review process.
A selection of newly published papers on self-care from the worldwide literature
Every week, we will provide a brief summary and a link to the published abstract of newly published papers selected from the worldwide literature as being of particular interest to the SelfCare community.